|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0080 - 0.0100|
|52 Week Range||0.0055 - 0.0360|
|Beta (5Y Monthly)||0.39|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
OWC Pharmaceutical Research Corp. (OTCQB: OWCP) ("OWCP") announced that, on Sep. 14, 2020, the Company signed an international distribution agreement with Can It Industries from Florida, US.
OWC Pharmaceutical Research Corp. (OTCQB: OWCP) ("OWCP") announced that, on Aug 31, 2020, the company will be holding a shareholders meeting to vote on a Reverse Split ("R/S") and increasing the Authorized shares ("A/S").
OWC Pharmaceutical Research Corp. (OTC: OWCP) ("OWC"), announced that it will be holding a special meeting of stockholders to vote on a reverse stock split (the "Reverse Split") at a ratio between 1:10 and 1:20 as outlined in the company's recently filed proxy statement. The meeting is tentatively scheduled for August 25, 2020.